Your browser doesn't support javascript.
loading
Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization.
Lam, Alex K; Roshan, Romin; Miley, Wendell; Labo, Nazzarena; Zhen, James; Kurland, Andrew P; Cheng, Celine; Huang, Haigen; Teng, Pu-Lin; Harelson, Claire; Gong, Danyang; Tam, Ying K; Radu, Caius G; Epeldegui, Marta; Johnson, Jeffrey R; Zhou, Z Hong; Whitby, Denise; Wu, Ting-Ting.
Afiliação
  • Lam AK; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Roshan R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Miley W; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Labo N; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Zhen J; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Kurland AP; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Cheng C; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Huang H; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Teng PL; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Harelson C; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Gong D; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Tam YK; Acuitas Therapeutics, Vancouver, British Columbia, Canada.
  • Radu CG; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Epeldegui M; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Johnson JR; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Zhou ZH; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Whitby D; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Wu TT; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
J Virol ; 97(2): e0160022, 2023 02 28.
Article em En | MEDLINE | ID: mdl-36757205
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 8 / Anticorpos Neutralizantes Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 8 / Anticorpos Neutralizantes Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos